Princess of the Void - Survey for vol 5
- Option 1 45
- Option 2 124
Hello pals! I have a survey just for you. Originally this was going to be for only super pals but I forgot to check the button. So get in here, pals!
Warning that this post contains spoilers for Volume 5 and specifically the next chapter, which I am in the process of drafting. It concerns a plot element that I am considering exploring in Princess of the Void; I'm hemming and hawing on it and I figure I might as well bring it to you guys and gather some early impressions since you as pals are the most invested in my work and deserve nice things.
So next chapter involves a check-up on Sykora's babies with Grant. I have two ways that this can go which will play a major role in the way the series continues, and while I weigh them I want your opinions on how you'd prefer it.
Option 1: Axyna checks in on the embryos and concludes that Sykora is going to have three healthy Taiikari babies (with one son who will inherit his father's immunity)
Option 2: Axyna checks in on the embryos and concludes that Sykora is going to have three healthy Taiikari babies (with one son who will inherit his father's immunity)... and they'll grow up to be Maekyonite-sized.
Option 2 follows up on some hints first seeded (pun intended) in volume 2 about the disarming closeness Taiikari and humans have. If the story goes this way, babies born to human and Taiikari pairings will have the chance to inherit their Maekyonite parent's stature. Grant and Sykora will have to choose together whether it's better to let this unexpected hybridization happen, along with all the massive implications for the future of both species, or intervene to medically correct it and have the kids be born standard Taiikari.
Is this an interesting and fun idea, or one that further strains the already-shaky biological credulity/creates metaphors and conversations you'd rather not read about?
As always the results of this vote are nonbinding!! I just want to get a first thought on where people's heads are at.